Entrepreneur and investor Mark Cuban has become one of healthcare's most prominent disruptors, taking aim at high drug prices through the Mark Cuban Cost Plus Drug Company while pushing for greater transparency and competition across the healthcare system.
Known to millions from Shark Tank, Cuban has built businesses by challenging established industries and betting on innovation. As healthcare races to deploy artificial intelligence, manage rising costs and adapt to regulatory change, industry leaders are debating how new technologies can improve care while making the system more affordable and accessible.
At Reuters Events Total Health in Nashville, Reuters U.S. Health and Pharma Editor Caroline Humer speaks with Cuban about AI's potential in medicine, efforts to lower prescription drug costs, the future of healthcare investment, and what it will take to build a more efficient, transparent and patient-centered healthcare system.
Â
